Arkema Exhibits at CPhI 2006, Paris, from October 3 to 5, 2006, Hall 5, Stand 5E18
Oct 3, 2006
Arkema officially launches its new organic oxidation catalyst, Oxynitrox® S100, at the CPhI 2006 tradeshow in Paris, from October 3rd to 5th.
A world leading producer in a number of fine chemicals sectors, Arkema also presents over 20 products used in Cosmetics and Polymer manufacture, as well as in the Pharmaceutical industry in which they are proving effective building block reagents in the manufacture of a very wide range of therapeutic products, while also promoting the synthesis of new drugs.
Oxynitrox® S100, a new totally organic oxidation catalyst, with applications primarily in the pharmaceuticals, cosmetics and fragrance markets.
Hydrazine Hydrate and Derivatives - salts and triazoles -, to enhance your activity.
Triazoles are synthesis intermediates derived from hydrazine hydrate. Arkema currently markets four products: 1,2,4-triazole, 1,2,4-triazole sodium salt, 4-amino-1,2,4-triazole, and 3-amino-1,2,4-triazole, which have a number of applications in the synthesis of active ingredients for pharmaceutical, veterinary and phytosanitary products.
Aminoguanidine Bicarbonate (AGBC) offers the pharmaceutical industry a high purity product that allows producers to skip a step in synthesis processes, and helps minimize effluents. AGBC is ideally suited to the synthesis of antidepressants and antineoplastic medications.
Specialty Thiochemicals, with a complete portfolio of organosulfur derivatives used to produce molecules and countless active ingredients across all therapeutic fields, ranging from everyday fungicides, antibiotics, antihypertensives, anti-ulcer drugs, anti-inflammatories etc., to well-known antivirals.
Sodium Methyl Mercaptan (SMM) is available in wide-ranging grades as aqueous or methanol solutions, in drum or in bulk, for pharmaceutical and chemical synthesis.
Thioglycolic Acid and Derivatives are used in the cosmetics market for cold permanent wave preparations and depilatory creams and lotions.
An extensive Sulfonyl range comprises Methane Sulfonic Acid (MSA) and Methane Sulfonic Chloride (MSC), as well as other Alkane Sulfonyls. Sulfonyls are used in various markets, including pharmaceuticals and esterification catalysis.
Dimethylsulfoxide (DMSO), a polar aprotic solvent, unlabeled, and safe for man and the environment, is very effective in organic fine chemical and polymer synthesis. Recyclable, Arkema’s DMSO is widely used as a reaction solvent because of its effectiveness and beneficial toxicological properties.
Specialty and Alkyl Amines (AA), Alkyl Alkanolamines (AAA) and Alkyl Hydroxylamines (DEHA) represent a comprehensive product portfolio for a wide range of pharmaceutical and cosmetics applications.
Among its range of specialty amines, Arkema has developed a highly selective amine, EDIPA (ethyl di-isopropylamine) to fulfill the specific requirements of manufacturers in the field of pharmaceutical synthesis. EDIPA is particularly effective in alkylation, acylation and elimination reactions, coproducing hydracids (HCl, HBr, etc.). This tertiary amine is neither nucleophilic nor sensitive to alkylation. These properties allow EDIPA to neutralize hydracids during synthesis without affecting the molecules, thereby improving productivity.
Boron Trifluoride gas and complexes: your worldwide catalyst!
BF3 gas and complexes are used in the synthesis of lubricant additives, resins, fragrances and flavors, and pharmaceutical intermediates (as catalysts for antibiotics like cephalosporins and quinolones).
As a global supplier, Arkema is committed to providing high quality products and services to its customers all over the world.
Through its subsidiary Ceca, Arkema also offers a range of Clarcel® filter aid and Acticarbone® activated carbon. One of the major applications of activated carbon is the elimination of impurities in the synthesis of pharmaceutical intermediates.
Diatomite, perlite and precipitated silica from the Clarcel® range are used both in the filtration of pharmaceuticals and as a functional additive in diverse applications ranging from cosmetics and dental impression to toothpaste and perfume manufacture.
A global chemical player, Arkema combines 3 related and integrated business segments: Vinyl Products, Industrial Chemicals, and Performance Products. Present in over 40 countries with 18,400 employees, Arkema achieves sales of 5.7 billion euros (2005). With its 6 research centers in France, the United States and Japan, and internationally recognized brands, Arkema holds leadership positions in its principal markets.
